Independent Institutes Search For New Sources Of Funding

'IN TRANSITION': Association of Independent Research Institutes members are looking at new strategies, says president David Beck. Independent research institutes, which garner 10 percent of the National Institutes of Health's extramural research funding budget, rely heavily on federal support. With increased competition for grants and government funding far from assured, these institutes are reevaluating their financial strategies. Members of the Association of Independent Research Institutes

Written byMyrna Watanabe
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share


'IN TRANSITION': Association of Independent Research Institutes members are looking at new strategies, says president David Beck.
Independent research institutes, which garner 10 percent of the National Institutes of Health's extramural research funding budget, rely heavily on federal support. With increased competition for grants and government funding far from assured, these institutes are reevaluating their financial strategies. Members of the Association of Independent Research Institutes (AIRI) report that they are "in transition," according to AIRI president David Beck. Some are rethinking their foci, while others are fusing with other organizations, seeking research partners, or looking at new sources of revenue. "This is sort of new," says Beck. He explains that although these institutes are not going through "hard times," some are looking for "a way to stabilize" funding.

Independent research institutes vary in size and focus. AIRI consists of approximately 85 diverse members. They can be small organizations like Great ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies